The U.S. Food and Drug Administration on Thursday approved Biohaven Pharmaceutical Holding Co Ltd's oral pill for relieving pain after the onset of migraine headaches, the drug developer said.
from Reuters: Company News https://ift.tt/2Tp6Twm
via IFTTT
0 comments:
Post a Comment